Pernilla Abrahamsson
Directeur des opérations chez LIPUM AB
Profil
Pernilla Abrahamsson is the founder of MD Biomedical AB.
She is currently the Chief Operating Officer at Lipum AB.
Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Postes actifs de Pernilla Abrahamsson
| Sociétés | Poste | Début |
|---|---|---|
| LIPUM AB | Directeur des opérations | 01/01/2019 |
Anciens postes connus de Pernilla Abrahamsson
| Sociétés | Poste | Fin |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01/04/2019 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Fondateur | - |
Formation de Pernilla Abrahamsson
| Umea Universitet | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SENZIME AB | Health Technology |
| LIPUM AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
